ORMP
Oramed Pharmaceuticals Inc
Price:  
2.40 
USD
Volume:  
126,171.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ORMP Relative Valuation

-12.1%
Upside

As of 2025-02-19, the Relative Valuation of Oramed Pharmaceuticals Inc (ORMP) is 2.11 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.40 USD, the upside of Oramed Pharmaceuticals Inc based on Relative Valuation is -12.1%.

The range of the Relative Valuation is 1.66 - 2.63 USD.

Range Selected
Trailing P/E multiples 17.4x - 23.7x 19.8x
Forward P/E multiples 17.1x - 24.2x 20.8x
Fair Price 1.66 - 2.63 2.11
Upside -30.8% - 9.4% -12.1%
2.40 USD
Stock Price
2.11 USD
Fair Price

ORMP Relative Valuation - Historical P/E Data

Date P/E
2025-02-14 21.67
2025-02-13 22.12
2025-02-12 22.30
2025-02-11 23.47
2025-02-10 19.59
2025-02-07 19.59
2025-02-06 19.95
2025-02-05 19.77
2025-02-04 19.77
2025-02-03 19.50
2025-01-31 20.22
2025-01-30 19.86
2025-01-29 20.31
2025-01-28 20.31
2025-01-27 20.22
2025-01-24 20.49
2025-01-23 20.76
2025-01-22 20.85
2025-01-21 20.76
2025-01-17 20.58
2025-01-16 20.94
2025-01-15 21.13
2025-01-14 21.31
2025-01-13 21.31
2025-01-10 21.58
2025-01-08 21.49
2025-01-07 21.85
2025-01-06 22.12
2025-01-03 22.03
2025-01-02 21.76
2024-12-31 21.85
2024-12-30 21.04
2024-12-27 21.40
2024-12-26 21.31
2024-12-24 21.49
2024-12-23 21.49
2024-12-20 21.40
2024-12-19 22.48
2024-12-18 21.67
2024-12-17 21.22
2024-12-16 21.58
2024-12-13 22.30
2024-12-12 22.48
2024-12-11 22.21
2024-12-10 22.66
2024-12-09 22.75
2024-12-06 21.67
2024-12-05 22.66
2024-12-04 22.75
2024-12-03 22.21